The history of sclerosing foams
- PMID: 15099310
- DOI: 10.1111/j.1524-4725.2004.30208.x
The history of sclerosing foams
Erratum in
-
Re: The history of sclerosing foams.Dermatol Surg. 2005 Feb;31(2):249. doi: 10.1111/j.1524-4725.2005.31055. Dermatol Surg. 2005. PMID: 15762226 No abstract available.
Abstract
Background: The use of foamed sclerosants in phlebology is undergoing a renaissance. The use of foam sclerotherapy was relaunched only a few years ago. Despite this, the early developments, pioneer findings, and improvements, especially in foaming techniques, are not widely recognized.
Objective: The objective of this study was to give an overview from the very beginnings of foam sclerotherapy until the most recent and progressive techniques, as described by Tessari or the double syringe system technique.
Results: The publications found after a thorough research for literature about foam sclerotherapy allow us to examine what has been invented between Orbach's work in 1944 and now and--surprisingly--even before 1944. The contributions of greatly reputed and also of unknown colleagues, such as Orbach, Sigg, Mayer, or Flückiger, are presented, giving a historical overview from the very beginnings of foam sclerotherapy until the most recent techniques. Basically, the literature shows that remarkable work was carried out in the field of noncommercial foam sclerotherapy and that sclerosing foams have been used by numerous doctors continuously for the past six decades, especially for the treatment of varicose veins of the lower limbs.
Conclusion: The use of foamed sclerosing agents in therapy of large or small varicose veins is not new. It started as early as 1939 and has continuously been improved in the past decades.
Comment in
-
Dr J. Cabrera is the creator of the patented polidocanol microfoam.Dermatol Surg. 2004 Dec;30(12 Pt 2):1605; author reply 1606. doi: 10.1111/j.1524-4725.2004.30580_1.x. Dermatol Surg. 2004. PMID: 15606858 No abstract available.
Similar articles
-
European Consensus Meeting on Foam Sclerotherapy, April, 4-6, 2003, Tegernsee, Germany.Dermatol Surg. 2004 May;30(5):709-17; discussion 717. doi: 10.1111/j.1524-4725.2004.30209.x. Dermatol Surg. 2004. PMID: 15099312 Review.
-
Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.Dermatol Surg. 2003 Dec;29(12):1170-5; discussion 1175. doi: 10.1111/j.1524-4725.2003.29398.x. Dermatol Surg. 2003. PMID: 14725657 Clinical Trial.
-
A history of injection treatments - II sclerotherapy.Phlebology. 2019 Jun;34(5):303-310. doi: 10.1177/0268355518798283. Epub 2018 Oct 18. Phlebology. 2019. PMID: 30336757
-
Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?J Drugs Dermatol. 2008 Apr;7(4):399-400. J Drugs Dermatol. 2008. PMID: 18459524
-
Foam sclerotherapy--a possible option in therapy of varicose veins.J Dtsch Dermatol Ges. 2007 Aug;5(8):648-54. doi: 10.1111/j.1610-0387.2007.06310.x. J Dtsch Dermatol Ges. 2007. PMID: 17659037 Review. English, German.
Cited by
-
S2k guidelines: diagnosis and treatment of varicose veins.Hautarzt. 2022 May;73(Suppl 1):1-44. doi: 10.1007/s00105-022-04977-8. Epub 2022 Apr 19. Hautarzt. 2022. PMID: 35438355 Free PMC article. Review. No abstract available.
-
Sclerotherapy in the treatment of varicose veins : S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP.Hautarzt. 2021 Dec;72(Suppl 2):23-36. doi: 10.1007/s00105-020-04705-0. Hautarzt. 2021. PMID: 33252705 Free PMC article. Review. No abstract available.
-
[Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].Hautarzt. 2021 Jan;72(1):50-64. doi: 10.1007/s00105-020-04707-y. Hautarzt. 2021. PMID: 33151348 Review. German. No abstract available.
-
Percutaneous Lauromacrogol Foam Sclerotherapy for the Treatment of Acute Airway Compression Caused by Lymphatic Malformations in Infants.Biomed Res Int. 2018 Oct 18;2018:3878960. doi: 10.1155/2018/3878960. eCollection 2018. Biomed Res Int. 2018. PMID: 30498754 Free PMC article. Clinical Trial.
-
Exacerbation of alopecia areata: A possible complication of sodium tetradecyl sulphate foam sclerotherapy treatment for varicose veins.SAGE Open Med Case Rep. 2017 Jun 2;5:2050313X17712643. doi: 10.1177/2050313X17712643. eCollection 2017. SAGE Open Med Case Rep. 2017. PMID: 28616235 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous